13.01.2011
FDA To Limit Acetaminophen in Prescription Combination Products
BETHESDA, MD 13 January 2011—FDA today unveiled a three-year plan to remove from the U.S. market prescription combination pain relievers that contain more than 325 mg of... |
|
06.01.2011
Teva Recalls Metronidazole 250-mg Tablets
BETHESDA, MD 06 January 2011—Teva Pharmaceuticals U.S.A. today announced a follow-up to its October 2010 recall of 250-mg metronidazole tablets in 250-count bottles. This... |
|
29.12.2010
Children`s Hospitals Gain Legislative Victory on 340B Orphan Drugs
BETHESDA, MD 29 December 2010—Children`s hospitals got an early holiday present from Capitol Hill—the passage of legislation that reinstates 340B discounts for orphan drug... |
|
29.12.2010
Health Care Reform Means Challenges, Opportunities in Rural Areas
ANAHEIM, CA 29 December 2010—In rural America and elsewhere, health care reform is essentially about providing better, more cost-efficient care—issues that pharmacists are... |
|
17.12.2010
Propoxyphene Withdrawal Not a Crisis, Pharmacists Say
BETHESDA, MD 17 December 2010—FDA officials in November urged health care providers to help patients who have been using propoxyphene find alternatives to the now-banned... |
|
24.11.2010
Pharmacy Practice Model Initiative Finishes Consensus-Building Process
IRVING, TX 24 November 2010—The project to develop and disseminate optimal models of practice for pharmacists in hospitals and health systems reached a milestone last month:... |
|
01.11.2010
Counterfeit Drugs Pose Growing Health Threat
WASHINGTON, D.C. 01 November 2010—Counterfeit and substandard medicines constitute a real and growing threat to public health, say federal officials and others who deal with... |
|
29.10.2010
Companies Look for Profit in Orphan Drugs
SAN FRANCISCO, CA 29 October 2010—With the traditional path to drug approval strewn with obstacles, the pharmaceutical industry has identified a perhaps less-bumpy route:... |
|
28.10.2010
Book Correction Notice for `Pediatric Injectable Drugs, Ninth Edition`
BETHESDA, MD 28 October 2010—There are three new, important corrections to monographs in Pediatric Injectable Drugs, Ninth Edition (The Teddy Bear Book), published by ASHP. ... |
|
21.10.2010
New Diabetes, Cardiovascular Warnings Needed for Prostate Cancer Drugs
BETHESDA, MD 21 October 2010—FDA announced yesterday that it is requiring revisions to the labeling for gonadotropin-releasing hormone (GnRH) agonists to warn that they... |
|
